August 31, 2014 7:29 AM ET

Oil, Gas and Consumable Fuels

Company Overview of Elf Aquitaine S.A.

Executive Profile

Robert Castaigne

Independent Director and Member of Audit Committee, Sanofi
AgeTotal Calculated CompensationThis person is connected to 7 Board Members in 7 different organizations across 10 different industries.

See Board Relationships
68$120,000

Background

Mr. Robert Castaigne served as the Chief Financial Officer of Total SA (formerly, Total Fina Elf S.A.) from 1994 to June 1, 2008, Officer since 1990 and also served as its Executive Vice President until June 1, 2008. Mr. Castaigne started his career at TOTAL in 1972, where he served as an Engineer since January 1, 1972 and as Departmental Head within the Economic Division until 1977. He served as the Head of The Exploration-Production subsidiaries at TOTAL from 1977 ...

Corporate Headquarters

Tour Elf
Courbevoie, Ile-de-France 92400

France

Phone: 33 1 47 44 45 46
Fax: 33 1 47 44 78 78

Board Members Memberships

Director
Director
Director and Member of Audit Committee
1992-2004
Former Director
1999-N/A
Former Director
2000-Present
Independent Director and Member of Audit Committee
2007-Present
Director, Member of Audit Committee and Member of Remuneration Committee
2008-N/A
Independent Non-Executive director and Member of Audit Committee
2009-Present
Independent Director
2009-Present
Company Director and Member of Audit, Internal Control & Risk Committee

Education

Unknown/Other Education
Ecole Nationale Superieur du Petrole et des Moteurs
Unknown/Other Education
Ecole Centrale des Techniques de l'Environnement Industriel
Doctorate
University of Paris I--Sorbonne

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

Total Annual Cash Compensation$120,000
Total Calculated Compensation$120,000
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Robert A. Bradway Chairman, Chief Executive Officer, President, Chairman of Executive Committee and Member of Equity Award Committee
Amgen Inc.
$1.5M
John C. Martin Ph.D.Chairman and Chief Executive Officer
Gilead Sciences Inc.
$1.6M
Marijn E. Dekkers Ph.D.Chairman of Management Board and Chief Executive Officer
Bayer AG
$2.9M
Andrew Philip Witty Chief Executive Officer, Executive Director, Member of Corporate Administration & Transactions Committee and Member of Finance Committee
GlaxoSmithKline plc
$2.9M
Kenneth C. Frazier Chairman and Chief Executive Officer
Merck & Co. Inc.
$1.5M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Elf Aquitaine S.A., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.